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Abstract
Background: It is expected that, by 2020, 15 million new cases of cancer will occur every year in the world, one
million of them in Africa. Knowledge of cancer trends in African countries is far from adequate, and improvements
in cancer prevention efforts are urgently needed. The aim of this study was to characterize breast cancer clinically
and pathologically at presentation in Luanda, Angola; we additionally provide quality information that will be useful
for breast cancer care planning in the country.
Methods: Data on breast cancer cases were retrieved from the Angolan Institute of Cancer Control, from 2006 to
2014. For women diagnosed in 2009 (5-years of follow-up), demographic, clinical and pathological information, at
presentation, was collected, namely age at diagnosis, parity, methods used for pathological diagnoses, tumor
pathological characteristics, stage of disease and treatment. Descriptive statistics were performed.
Results: The median age of women diagnosed with breast cancer in 2009 was 47 years old (range 25–89). The most
frequent clinical presentation was breast swelling with axillary lymph nodes metastasis (44.9 %), followed by a mass
larger than 5 cm (14.2 %) and lump (12.9 %). Invasive ductal carcinoma was the main histologic type (81.8 %). Only
10.1 % of cancer cases had a well differentiated histological grade. Cancers were diagnosed mostly at advanced stages
(66.7 % in stage III and 11.1 % in stage IV).
Discussion: In this study, breast cancer was diagnosed at a very advanced stage. Although it reports data from a single
cancer center in Luanda, Angola it reinforces the need for early diagnosis and increasing awareness. According to the
main challenges related to breast cancer diagnosis and treatment herein presented, we propose a realistic framework that
would allow for the implementation of a breast cancer care program, built under a strong network based on cooperation,
teaching, audit, good practices and the organization of health services.
Conclusion: Angola needs urgently a program for early diagnosis of breast cancer.
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Background
It is expected that by 2020, 15 million new cases of cancer
will occur every year in the world, one million of them in
Africa. Knowledge of cancer trends in Africa is far from
adequate, and all efforts to develop population based can-
cer registries are needed to obtain reliable data to guide
Public Health authorities in planning and implementing
cancer control programs, aiming to reduce cancer inci-
dence, and related morbidity and mortality [1].
The cancer burden in Africa, including Angola, is likely
to increase in the forthcoming decades, due to the in-
creasing life expectancy of the population, changes in life-
styles associated with economic development, and longer
survival of HIV patients receiving antiretroviral therapy,
as HIV/AIDS patients have a substantially higher risk of
developing cancer than the general population. The con-
trol of communicable diseases is certainly very important,
but improvements of primary, secondary, and tertiary pre-
vention efforts to deal with non-communicable diseases,
including cancer, are urgently needed [2].
Angola has merely 3,541 doctors, 34,300 nurses and
6,414 health technicians for around 24.3 million people
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(48 % males and 52 % females), with a life expectancy at
birth of 52 years. There are seven medical schools and
several professional schools for nurses and other health
professionals [3]. About 12 pathologists currently work in
Angola. According to Trading Economics (Angola/indica-
tors) and International Monetary Fund, the gross domes-
tic product (GDP) in Angola was worth 124.18 billion
USD in 2013, although it is largely dependent on oil price
[4]. The Government has recently decided a new National
Cancer Plan, which is a visionary and ambitious initiative
to improve cancer control in the country [5].
The Angolan Institute of Cancer Control (IACC), former
National Oncology Center of Luanda, is the oldest public
center for the treatment of cancer patients in Angola. It has
chemotherapy and radiotherapy facilities, diagnostic cap-
abilities and experienced professionals. The Sagrada Esper-
ança Clinic belongs to a public company named Endiama.
This clinic has pathology facilities and a unit for the
diagnosis, treatment and monitoring of breast diseases,
with multidisciplinary treatment decisions implemented.
At present, the clinic is organizing a chemotherapy ser-
vice, as well as a unit for control of chronic pain and a
breast cancer screening program for Endiama employees.
The Girassol Clinic belongs to the public company Sonan-
gol. This clinic has the capacity for diagnostic imaging, as
well as pathological facilities. It also has a specifically built
oncology service, with a dedicated ward, an outpatient hos-
pital, a radiotherapy unit, a chemotherapy unit and Nuclear
Medicine resources. The Américo Boavida Hospital, the
David Bernardino Pediatric Hospital and the Josina Machel
Hospital are all teaching hospitals where most of the can-
cer patients are diagnosed. These hospitals are able to per-
form pathological diagnosis by histology or cytology [6].
Breast cancer is the second most common cancer among
women in Sub-Saharan Africa [7]. According to the Inter-
national Agency for Research on Cancer (GLOBOCAN),
the estimated breast cancer incidence rate in 2012 in
Angola was 23.5 per 100 000 women, and the mortality
rate was 11.7 per 100 000 [8]. In Angola, amongst the gen-
eral population and university students, awareness and
knowledge about breast cancer are extremely limited [9].
Our study aims to characterize breast cancer clinically and
pathologically at presentation in Luanda, Angola; we add-
itionally provide quality information that will be useful for
breast cancer care planning in the country.
Methods
Study design, setting and data collections
Records of the Angolan Institute of Cancer Control, from
2006 to 2014, were reviewed by trained doctors, and infor-
mation on the number of breast cancer cases was ab-
stracted using a standard form.
In order to study a cohort of patients with a follow-up
of 5 years, we decided to study all patients admitted and
treated in the year 2009. We further abstracted more de-
tailed information for this subset of patients, including
data on age at diagnosis, parity, methods used for patho-
logical diagnoses, tumor pathological characteristics, stage
of disease, and treatment. Breast tumors were classified
according to the 6th edition of TNM classification, which
is based on the size of the primary tumor and presence of
metastatic regional lymph nodes and/or of distant metasta-
ses [10]. Physical breast examination, mammography and/
or breast ultrasound examination and fine-needle aspir-
ation (FNA) are the commonly used diagnostic methods.
Histology and FNA slides were reviewed by a pathologist
according to the WHO classification [11].
Statistical analysis
Descriptive statistics are given as frequencies, median,
mean, minimum and maximum for continuous variables
and as percentages for categorical variables. Kruskal-Wallis
test was used to evaluate the differences in the median age
according to stage for cases admitted and treated in 2009.
Statistical analyses were performed using PASW Statistics
for Windows, Version 18.0, 2009. Chicago: SPSS Inc. ®.
Ethics
Permission to carry out this study was obtained by the
Angolan Ministry of Health and corresponding ethics
committee.
Results
From 2006 to 2014 there were 1,843 women admitted and
treated with a diagnosis of breast cancer (Fig. 1). The me-
dian age at diagnosis was 47 years (16–87 years). The fol-
lowing distribution of the stage of disease was found: stage
0–2.1 %; stage I - 3.5 %; stage II - 12.2 %; stage III - 54.2 %;
stage IV - 1.9 %; unclassified - 26.1 % (Table 1). Since no
complete information on stage was available for the entire
period, we could not evaluate if there were significant differ-
ences in the median age according to stage. However, using
only data from 2009, no significant differences were found
(p= 0.1). Invasive ductal cancer was the most common
histologic type of breast cancer found in the whole series.
In 2009, a total of 225 women were admitted for treat-
ment. Table 2 shows the women’ demographic, clinical
and breast cancer information for year 2009. The median
age of these women was 47 years (25–89 years); the ma-
jority of them were multiparous (72 %). Complete replace-
ment of breast tissue, nipple retraction and deviation,
oedema and ulceration of overlying skin, breast swelling
with axillary nodal involvement were the most frequent
clinical presentation. Invasive ductal carcinoma was the
predominant histological type (81.8 %). Of all breast
cancers diagnosed in 2009, 25.2 % were grade III (poorly-
differentiated) tumors. FNA was performed in all cases
and 37 % of these were histologically confirmed. All
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surgical specimens were histologically examined. An IHC
reaction to define the molecular profile was only per-
formed in one patient of this series and for this reason this
variable was not considered for complementary ana-
lyses. Among the 225 cases, 176 (77.8 %) were classified
as stages III and IV. Follow-up data was available only
in 47.1 % (n = 106) of patients studied, with a median
follow-up of 13.4 months (1–53.9 months). Conse-
quently, no overall survival was calculated.
Modified radical mastectomy was performed in 152 pa-
tients (67.5 %), and neo-adjuvant chemotherapy was given
to 104 patients (46.2 %); adjuvant or palliative chemother-
apy was given to the remaining patients. The most fre-
quently used drugs were doxorubicin, cyclophosphamide,
paclitaxel, methotrexate, 5-FU, cisplatin, tamoxifen and
bisphosphonates. Less than 10 % of the patients of this
series (2009) had radiotherapy.
Discussion
This is the first paper characterizing the stage of breast
cancer in Luanda, Angola at presentation. We only had
access to data from a tertiary hospital in the capital city,
Luanda, and therefore our data cannot be considered as
representative of the true epidemiological pattern in
Angola, where many women with breast lesions, in
particular in remote areas, may never reach a health
care facility. According to our findings, breast cancer
diagnoses were performed mostly in multiparous young
pre-menopause women, as it has been reported in
others African studies [12, 13].
Breast cancer diagnosis was performed using physical
examination, ultrasound and radiological examinations,
and FNA. The modified triple test score (MTTS), which is
an integration of clinical breast examination, ultrasound
and FNA, may be introduced, since the MTTS showed
100 % diagnostic accuracy for breast cancer malignancy in
women under age 40 [14].
The exposure and outcome information in a cohort
study were identified retrospectively by using administra-
tive datasets and by reviewing patient charts, but these are
sometimes frail. Thus, the major limitation of this study is
the lack of information (missing data) in the aforemen-
tioned datasets, which limits data analysis and interpret-
ation. Although we do not have complete information on
overall survival, given that breast cancer was mostly di-
agnosed at advanced stages, prognosis is expected to be
very poor.
Mastectomy is the most widely used procedure for
treatment of breast cancer, but in this particular context
even well conducted surgeries have limited levels of ac-
complishment. No detailed information on tumour size
could be obtained, but lymph node metastases were found
mostly in the group of patients with a mass over 5 cm,
nipple or skin retraction and skin ulceration. This is in ac-
cordance with other studies, which have found a signifi-
cant association between lymph node metastasis and
tumour size [15].
Additionally, neo-adjuvant therapy is frequently used
to treat patients with locally advanced breast cancer,
but generally have little influence in the patient
Table 1 Age (years) distribution according to stage of the disease
Stage n (%) Mean Median Minimum Maximum
0 38 (2.1) 45.5 46 25 75
I 65 (3.5) 49.2 49 20 84
II 225 (12.2) 48.4 47 24 81
III 998 (54.2) 47.3 45 16 87
IV 35 (1.9) 44.1 44 23 60
unclassified 482 (26.1) 50.1 49 18 85
Fig. 1 Number of breast cancer cases admitted and treated per year at IACC
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outcome. A similar disturbing scenario was also de-
scribed in Nigeria [16].
Recently, after 2009, the National Oncological Centre
(IACC) and the private Girassol Clinic in Luanda have
installed radiotherapy facilities and recruited radiothera-
pists for working on a full-time basis, which is a promis-
ing advantage for breast cancer treatment. Currently, the
patients treated with radiation at IACC and Girassol
Clinic include breast cancer patients [17].
Accumulating molecular data may enable more accurate
diagnoses and support therapeutic decisions. It is well
established that according to the molecular profile of
breast cancer, translated by IHC characterization, a panel
of therapeutic actions should be addressed to minimize
the impact of the disease [18].
A pro-active program for early detection of breast cancer
and the complete characterization of the tumours should
be implemented in an Angola breast cancer programme
[19]. This country does not have the infrastructural capacity
in terms of health care facilities, professionals and budget
to implement and maintain a program for a population-
based screening programme.
Reliable statistics of cancer incidence and mortality in
Angola are not presently available. To allow for a proper
planning of both secondary and tertiary preventable ac-
tions for breast cancer, by properly planning health care
services, such statistics are needed. As suggested by
Harford et al., twining between countries with medium/
high income and low/middle income would allow the
sharing of knowledge and experience in cancer registra-
tion best practices and tools for breast (and other cancer
types) diagnosis and treatment [20]. Thus, cooperation
between a well functioning and established cancer regis-
try such as the Azores Cancer registry (Portugal) and
the African Cancer Registry Network (AFCRN) would
facilitate the establishment of a population-based cancer
registry - where all new cancer cases occurring in a de-
fined population are recorded - in Luanda. Hospital-
based registries can be the first important step into the
establishment of such a population-based cancer regis-
try. Moreover, collaboration enhances the potential of
both systems, especially in developing countries [21]. To
accomplish this, Angolan National Centre of Oncology
(IACC) has recently organized and sponsored a course
entitled ‘Cancer Registration – Principles and Methods’.
It is also impossible to ignore the impact that ultrasound
equipment has made within medical education. Ultra-
sound has played an essential role in point-of-care of
breast cancer diagnostics, and implementing ultrasound
training into medical education is the next logical step in
our breast cancer program.
“Municipalities against cancer” is a comprehensive edu-
cational program that includes general doctors, nurses
and teachers; it was created to discuss and plan strategies
Table 2 Demographic, clinical and pathological figures for
women included in study
Characteristics n (%)
Age (years)
20-29 10 (4.4)
30-39 37 (16.4)
40-49 91 (40,4)
50-59 47 (20.9)
60-69 23 (10.2)
70-79 12 (5.3)
80-89 5 (2.2)
Median 47 (range 25–89)
Parity
Nulliparous 7 (3.1)
Multiparous 162 (72)
Without information 56 (24.9)
Clinical presentation
Mammograms alteration 8 (3.6)
Lump (<5 cm) 29 (12.9)
Mass (>5 cm) 32 (14.2)
Nipple or skin retraction 21(9.3)
Ulcer 21(9.3)
Swelling and redness (inflammatory) 13 (5.8)
Breast swelling with axillar lymph nodes 101 (44.9)
Histhological Type
Ductal carcinoma in situ 2 (0.9)
Invasive ductal carcinoma 184 (81.8)
Invasive lobullar carcinoma 2 (0.9)
Medullary 9 (4)
Papillary 17 (7.6)
Squamous cell carcinoma 1 (0.4)
Mucinous 1 (0.4)
Sarcoma 1 (0.4)
No classified 8 (3.6)
Grade
I 45 (10.1)
II 123 (54.7)
III 57 (25.2)
Stage
0 2 (0.9)
I 4 (1.8)
II 44 (19.5)
III 150 (66.7)
IV 25 (11.1)
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for cancer control of cervix, breast and prostate malignan-
cies and patient management under the Angola Municipal
Health Services Strengthening Project. The aims of this
program are health education, early breast cancer diagnosis
and patient management (Fig. 2). The Breast Health Global
Initiative recommendations from the 2007 Summit were to
promote breast self-awareness and clinical breast examin-
ation (CBE) at the basic level and to encourage women to
seek medical evaluation of breast problems and diag-
nostic imaging, such as ultrasound and mammography,
for suspicious breast nodules [22]. Ultrasound is super-
ior and a cost effective alternative for the assessment of
the symptomatic young patient and is an optimal mo-
dality for imaging guidance to improve accuracy of
fine-needle aspiration [23]. General practitioners and
medical students should be offered training to learn
how to use this diagnostic tool.
Management of breast cancer requires an extensive
and urgent approach that combines actions such as: ef-
fective prevention, early diagnosis, surgical therapies and
Fig. 2 Medical education of general doctors of municipal hospitals regarding breast cancer. Specific consent to publish the images was obtained
from all individuals
Table 3 Urgent actions needed for breast cancer program in Angola
Task Actions
Structural developments Hospital-based cancer registries, as a crucial step in order to establish a population-based cancer registry in Luanda.
Capacity building and
awareness
“Municipalities against cancer” a comprehensive educational program that includes general doctors, nurses and teachers.
Diagnosis Early detection;
Proactive programme for early detection that includes clinical and ultrasound examination by municipal doctors.
Introduction of the modified triple test score (MTTS);
Tissue procurement (FNA and histology);
Pathology diagnosis accuracy and determination of ER, PR, HER2 and KI-67 (protein) status by IHC.
Treatment decision Multidisciplinary integrated treatment team in order to provide the most comprehensive treatment plan.
Adequate treatment Surgery: The best surgical treatment (Surgical oncology training);
Systemic therapy: drugs availability, affordability and uninterrupted supply, safe storage and preparation, adequate
prescription and administration, management of side effects;
Radiation therapy: to be included in breast treatment protocol, management of side effects related to radiation;
Accessibility to cost-effective chemotherapy or radiation therapy, and palliative care.
Follow-up Shared and supported follow-up program including all levels of care and adequate registration of follow-up data.
Palliative care Pain control and adequate management of end-of-life care.
ER estrogen receptor, PR progesterone receptor, IHC immunohistochemistry, HER2 human epidermal growth factor receptor, KI-67 (protein) proliferation marker
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timely access to cost-effective chemotherapy or radiation
therapy, as well as palliative care. Availability and afford-
ability of anticancer medicines is another important step
in this fight. Efforts should be made to ensure adequate,
cheap and uninterrupted supply of anticancer medicines,
and radiation treatments to breast cancer patients. Add-
itionally, molecular characterization of these neoplasms is
fundamental since this may condition the therapeutic pro-
file. However, a successful management of breast cancer
also requires specialized oncology-trained doctors (sur-
geons, medical oncologist and radiotherapists), nurses, im-
aging technicians and pathologists in order to develop a
proficient oncologic care and a multidisciplinary approach
(Table 3) [24].
Conclusion
In Luanda, Angola, breast cancer is common. Most cases
are diagnosed at an advanced stage, which predicts a poor
prognosis. Therefore, Angola needs a program for early
diagnosis of breast cancer. Clinical breast examination,
ultrasound and/or mammography and FNA may be useful
in this context. Radiotherapy is one of the fundamental
treatments at these stages and should be widely used.
The characterization of IHC/molecular breast cancer
subtypes is urgent, in order to achieve the best systemic
treatment approach.
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